Table 1.
Effects of probiotics on different disorders in experimental alcoholic liver disease
Disorder
|
Biomarker changes
|
Ref.
|
Liver steatosis | ↓ Liver mass, ↓ content of triglycerides, free fatty acids, and cholesterol in the liver tissues | [50-52,54] |
Liver inflammation | ↓ Myeloperoxidase activity, expression of tumor necrosis factor alpha gene and neutrophil infiltration in the liver | [54] |
Oxidative stress in liver | ↓ Level of nitric oxide and malondialdehyde and ↑ level of glutathione and catalase in the liver tissue | [50,51,54] |
Death of hepatocytes | ↓ Serum aminotransferases | [50-54] |
Systemic inflammation | ↓ Serum IL-6 and tumor necrosis factor alpha | [51-53] |
Bacterial translocation | ↓ Serum lipopolysaccharide | [51-54] |
Gut dysbiosis | ↑ Firmicutes, Clostridiales and Lactobacillales; ↓ Proteobacteria and Campylobacterales | [51,53] |
Damage to the intestinal epithelium | ↓ Serum diamine oxidase | [53] |
Increased intestinal permeability | ↓ Serum D-lactate, ↑ the amount of occludin and other protein of tight junction in the gut epithelium, ↓ intestinal permeability for dyes | [50,52-54] |
Dyslipidemia | ↓ Serum cholesterol and triglycerides | [50,52-54] |